Results

Total Results: 1,134 records

Showing results for "days".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - nephropathy (CIN), defined as an increase in serum creatinine of more than 25 percent or 0.5 mg/dL within 3 days … We found a borderline statistically significant reduction in short-term CIN risk (less than 7 days after
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_disposition-comments.pdf
    January 01, 2012 - #6 Results On the top of page 37, in the first full paragraph, the time interval for reduction in days … Is this a reduction in days over a one month time?
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
    October 01, 2023 - one falls prevention study.22 The PSP was associated with no difference in readmissions within 30 days … in one study23 and lower rates of readmission within 30 days in two studies (see Table C-3).24-26 These … was 8.78 and among those who did not submit checklist 11.5 (p=0.02) • Readmissions within 30 days … • Shorter hospital stays were correlated with higher application usage (high-usage group 8.3 days … in average, moderate- usage group 6.8 days in average, and low-usage group 7.1 days in average)
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
    January 01, 2020 - adults9 are safe in the short term (within 30 to 42 days following immunization) or long term (>42 days … recommended for U.S. children and adolescents in 201110 are safe in the short term (within 30 to 42 days … following immunization) or long term (>42 days after immunization)? … authors, these adverse events are very rare, and occurred at the rate of about 1 per 100,000 person-days … at seven months of age, compared to a high of five per 100,000 person-days at 17 months of age.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
    May 20, 2013 - The time needed to carry out the entire test should also be commented on as it is several days. … The most commonly employed method—obtaining a single radiograph at 5 days after ingesting a marker
  7. effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
    November 03, 2020 - Rates of protracted opioid prescribing (prescriptions renewed longer than 120 days) are less than 1% … them to avoid uncomfortable withdrawal symptoms.48, 49 Long-term opioid use—use of opioids on most days … It was a rural setting and it took two days for the central pharmacy to ship the medication to me. … my dosage in half after 28 years of taking exactly what I was prescribed three times a day for 365 days … My pain levels depend on how many times I must transfer to and from my wheelchair so on quiet days,
  8. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - patients would also need access to a highly trained, multidisciplinary care team 24 hours a day, 7 days … The recommended dosage for ranibizumab is 0.3 mg (0.05 mL) once monthly (every 28 days) by intravitreal
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - from lithotripsy, we excluded studies with participants who had undergone lithotripsy fewer than 90 days
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
    September 01, 2013 - East Asian), duration of followup (≤30 days vs. >30 days), and year when enrollment was started (continuous … disease subtype (acute coronary syndromes vs. coronary artery disease); duration of followup (≤30 days … vs. >30 days); and year when enrollment was started (continuous variable). … No clinical adverse ischemic outcomes were observed in either group at 7 or 20 days of followup. … The studies had short followup durations (1 year in one study, 6 months in another, and 30 days in the
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_disposition-comments.pdf
    October 23, 2012 - “This point is especially important because the functional skill training studied was conducted 5 days … “This point is especially important because the functional skill training studied was conducted 5 days
  12. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
    September 01, 2011 - various gestational ages (<28 weeks, < 32 weeks, <34 weeks, <37 weeks), mean prolongation of pregnancy (days … Matria-based cohort study, more women in the SQ terbutaline pump group had pregnancy prolonged > 7 days … statistically significant benefits in favor of the pump compared with oral tocolytics for prolongation > 14 days … - based cohort studies of women with RPTL and single or twin gestation (range of mean difference in days
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf
    December 01, 2018 - • Intervention group patients with Lung- RADS 4 findings had 20.1 days to follow up vs. 22 days … mammogram adherence than in the control group (p < 0.001),28 and were more likely to follow-up within 120 days … demonstrated an increase in the percentage of Latinas initiating breast cancer treatment within 30 and 60 days
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
    May 22, 2012 - atrial flutter):  Including paroxysmal AF (recurrent episodes that self-terminate in less than 7 days … ), persistent AF (recurrent episodes that last more than 7 days), and permanent AF (an ongoing long-term … (includes atrial flutter) o Paroxysmal AF (recurrent episodes that self- terminate in less than 7 days … ) o Persistent AF (recurrent episodes that last more than 7 days) o Permanent AF (an ongoing, long-term
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - We calculated the span of days for which the patient had prescriptions for both hydralazine and isosorbide … about 80% of patients who ever received an ACEI/ARB obtained their initial prescription within 30 days
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - The discussion period started 12 days after we received signed disclosure of interest forms from almost … All participants were contacted 5 days before the online discussion board was made available. … Four of 21 stakeholders signed in to the Web site within 2 days. … The median time until stakeholders signed in was 7 days. … prevent procrastination and further delay, we asked stakeholders to nominate the topics within 4 days
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
    November 28, 2012 - , quality of life o Intermediate outcomes: Time-to progression, local recurrence, length of stay, days … primary HCC Intermediate outcomes  Time to progression  Local recurrence  Length of stay  Days
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_consumer.pdf
    January 01, 2016 - Radiation treatment is given a few minutes a day, 5 days a week, for 8 to 9 weeks.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
    January 01, 2017 - Diagnosis and Management of Gout: Current State of the Evidence Diagnosis and Management of Gout: Current State of the Evidence Focus of This Summary This is a summary of two systematic reviews. One review evaluated the evidence regarding the accuracy and safety of tests used to initially diagnose gout in the pr…
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
    January 01, 2013 - Resource utilization, including overall financial cost, hospitalization rates, days in the hospital, … We excluded studies that provided CM for only short durations (30 days or less). … effective in improving resource utilization, including overall financial cost, hospitalization rates, days

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: